WAYNE, N.J., June 3, 2013 /PRNewswire-USNewswire/ -- "Bayer joins the nation in mourning the passing of Senator Frank Lautenberg," said Raymond F. Kerins, Jr., Senior Vice President of Communications, Public Affairs and Policy, Bayer Corporation.
"Senator Lautenberg was a firm supporter of patient access to excellent healthcare and of intellectual property," Mr. Kerins continued. "His energy and dedication to pursuing legislation to improve the lives of people in New Jersey and throughout the country were unmatched, and his passing is a great loss."
About Bayer Corporation
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an inventor company, it sets trends in research-intensive areas. Bayer's products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal 2012, the Group employed 110,500 people and had sales of 39.8 billion. In North America, Bayer had 2012 net sales of 9,576 million ($12,257 million) and employed 15,300 at year-end. For more information, go to www.bayerus.com.
SOURCE Bayer Corporation